Serum Thyroid-Stimulating Antibody, Thyroglobulin Levels, and Thyroid Suppressibility Measurement as Predictors of the Outcome of Combined Methimazole and Triiodothyronine Therapy in Graves' Disease-Reference-Cited by-同舟云学术

Serum Thyroid-Stimulating Antibody, Thyroglobulin Levels, and Thyroid Suppressibility Measurement as Predictors of the Outcome of Combined Methimazole and Triiodothyronine Therapy in Graves' Disease

Published:1991-01 Issue:4 Volume:1 Page:293-299
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

WERNER RUBENS S.,ROMALDINI JOAO H.,FARAH CHADY S.,WERNER MARISA C.,BROMBERG NAZARETH

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.1991.1.293

Reference25 articles.

1. Immunological Parameters in Graves’ Disease: Are They Useful for Indication and Monitoring of Antithyroid Drug Treatment?

2. Evaluation of TSH-receptor antibodies as prognostic markers after cessation of antithyroid drug treatment in patients with Graves' disease

3. Clinical Significance of Assay of Thyroid-Stimulating Antibody in Graves' Disease

4. Clinical Experience with a Human Thyroid Cell Bioassary for Thyroid-Stimulating Immunoglobin *

5. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum thyroglobulin is associated with orbitopathy in Graves’ disease;Journal of Endocrinological Investigation;2021-01-29

2. Comparison of three different assays for measuring thyroglobulin and thyroglobulin antibodies in patients with chronic lymphocytic thyroiditis;Clinical Biochemistry;2017-12

3. A mathematical model of pituitary–thyroid interaction to provide an insight into the nature of the thyrotropin–thyroid hormone relationship;Journal of Theoretical Biology;2007-09

4. The safety and efficacy of antithyroid drugs;Expert Opinion on Drug Safety;2005-12-22

5. Impacto médico-social do tratamento medicamentoso da moléstia de Graves-Basedow em Hospital Público Universitário: avaliação retrospectiva e projeção prospectiva de conduta terapêutica;Arquivos Brasileiros de Endocrinologia & Metabologia;2005-08